Amit Sachdev
CIK 1406338 · EVP Chief Patient & Ext Af Off · last filed 2026-02-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$28.86M
Companies
2
Total Filings
146
Lifetime Open-Market Net
-$171.36M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VRTX | EVP Chief Patient & Ext Af Off | 64,871 | $444.93 | $28.86M | -$171.36M | 141 | 2026-02-26 |
| Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Director | 16,000 | $1.73 | $27.6K | $0 | 5 | 2023-03-03 |
Recent Filings · Page 15 of 15
146 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-02-06 | VRTX | Grant (A) | +12,200 | $122 | EDGAR |
| 2008-11-19 | VRTX | Sell (S) | −791 | -$20.7K | EDGAR |
| 2008-07-25 | VRTX | Grant (A) | — | $0 | EDGAR |
| 2008-02-11 | VRTX | Grant (A) | +10,166 | $102 | EDGAR |
| 2007-11-07 | VRTX | Buy (P) | +1,000 | $24.7K | EDGAR |
| 2007-07-24 | VRTX | Grant (A) | +17,000 | $170 | EDGAR |
Showing 141–146 of 146
Prev
Page 15 of 15
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.